Answers are grounded in this paper and cite their sources.
Aims To examine characteristics associated with kinesiophobia and develop screening models for gastrointestinal cancer patients after surgery and hyperthermic intraperitoneal chemotherapy (HIPEC). Design A single-center cross-sectional study with internal model evaluation. Methods From October 2025 to May 2026, 521 patients were recruited by convenience sampling at a tertiary hospital in Liaoning Province, China. Candidate predictors and kinesiophobia were assessed on postoperative day 3 after clinical stabilization. A Tampa Scale for Kinesiophobia score ≥37 defined screening-positive status. LASSO and multivariable logistic regression were used for variable selection and association analysis. Logistic regression (LR), support vector machine (SVM), random forest (RF), and decision tree (DT) models were compared. A separate six-factor LR model was developed in 365 patients and evaluated in a same-center internal test set of 156 patients. Performance assessment included discrimination, classification, calibration, Brier scores, and decision curve analysis. Results Overall, 201 patients (38.6%) screened positive for kinesiophobia. Pain severity, anxiety, depression, general self-efficacy, postoperative catheter number, and comorbidities constituted the six-factor model. In the four-model comparison, test-set AUCs were 0.847 for RF, 0.842 for LR, 0.827 for SVM, and 0.730 for DT; corresponding Brier scores were 0.157, 0.153, 0.157, and 0.170. The separate six-factor model achieved a test-set AUC of 0.880 (95% CI, 0.825–0.934) and a Brier score of 0.144. At a probability threshold of 0.50, sensitivity was 76.92%, specificity was 78.85%, and the Youden index was 0.558. The calibration intercept-in-the-large and slope were −0.743 and 1.017, respectively; the Hosmer–Lemeshow test yielded χ 2 = 15.631 (df = 8; P = 0.048), indicating imperfect calibration. At a 20% assessment threshold, net benefit was 0.236, compared with 0.167 for assessing all patients. Conclusions The six-factor model demonstrated favorable discrimination for contemporaneous screening but overestimated screening-positive probability overall. Independent external validation, assessment of recalibration, and prospective clinical impact evaluation are required before routine implementation.
No takes yet. Share an insight, caveat, or question.
Li et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: